ASX:RMDHealth Care Equipment & ServicesHealth Care Equipment
RESMED CDI
$32.210
$0.520 (1.59%)
Day Range
$32.180 - $32.520
52 Week Range
$31.600 - $45.250
Volume
725.63K
Market Cap
$18.49B
Price Chart
Market Statistics
Open$32.280
Previous Close$32.730
Day High$32.520
Day Low$32.180
52 Week High$45.250
52 Week Low$31.600
Valuation
Market Cap18.49B
Shares Outstanding574.16M
Trading Activity
Volume725.63K
Value Traded23.41M
Bid$32.210 × 288
Ask$32.500 × 150
Technical Indicators
RSI (14)37.64
50-Day SMA$35.145
200-Day SMA$38.844
Latest News
ASX 200Biotechnology
ResMed delivers double-digit EPS growth on increasing demand for sleep apnoea devices
ResMed (ASX: RMD) has reported double-digit earnings per share (EPS) growth for the three months to March on the back of increasing market demand for its best-in-class sleep apnoea products and software solutions. The company’s revenue for the period increased by 8% to US$1.3 billion (up 9% on a constant currency basis), while income from […]
2 min read
ASX 200Technology
ResMed shares hit as Eli Lilly’s weight loss drug demonstrates sleep apnoea benefits
Medical device maker ResMed (ASX: RMD) saw its shares tumble more than 13% after pharmaceutical rival Eli Lilly announced that its weight-loss drug Zepbound (tirzepatide) could also help resolve sleep apnoea in some patients. California-based ResMed is a giant in the sleep apnoea space, manufacturing face masks, nasal devices and continuous positive airway pressure (PAP) […]
2 min read